Sign in
NAVB Stock Price, Chart, Stats & News
Navidea Biopharmaceuticals, Inc.
Save
Navidea Biopharmaceuticals, Inc. (NAVB) does not currently pay a dividend.
10,008
Market cap
–
Current P/E
–
Forward P/E
NAVB chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical firm dedicated to creating and marketing highly specific diagnostic tools that leverage the immune system, as well as therapeutic agents also based on immune principles. Its operations are divided into two primary divisions: Diagnostic Substances and Therapeutic Development Programs. Central to its efforts is the Manocept platform, designed to selectively bind to the CD206 mannose receptor found on activated macrophages.
Similar securities
Based on sector and market capitalization
Report issue